CeriBell, Inc (CBLL NASDAQ) stock market data APIs
$15.6419
0.3(1.9%)
as of July 18, 2025
Try our APIs with
free plan!
CeriBell, Inc Financial Data Overview
Price chart is built with
Anychart
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Prev. Close
15.6419
Open
15.9411
High
15.7311
Low
15.5441
52 wk Range
10.01-32.749
Market Cap
768 M
Shares Outstanding
35 824 K
Revenue
60 041 K
EPS
-0.36
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CeriBell, Inc data using free add-ons & libraries
Get CeriBell, Inc Fundamental Data
CeriBell, Inc Fundamental data includes:
- Net Revenue: 60 041 K
- EBITDA: -34 196 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-08
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CeriBell, Inc News
New
CeriBell shares drop 38% following InvestingPro's overvaluation warning
In October 2024, InvestingPro’s Fair Value model identified significant overvaluation in CeriBell, Inc. (NASDAQ:CBLL), a healthcare technology company specializing in seizure diagnostic solutions. T...
Ceribell (CBLL) CEO Chao sells $442,500 in stock
Ceribell, Inc. (CBLL) President and CEO Chao Xingjuan, sold 25,000 shares of common stock on July 7, 2025, for a total of $442,500. The shares were sold at prices ranging from $17.02 to $18.7. The tra...
Ceribell sues Natus Medical for patent infringement
[Judge gavel and law books in court background] CeriBell (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]) said on Monday that it has taken legal action against Natus Medical and its units, claimi...
Ceribell files patent infringement complaints against Natus Medical
SUNNYVALE, Calif. - Medical technology company Ceribell, Inc. (NASDAQ:CBLL), currently valued at $684 million, announced Monday it has filed complaints against Natus Medical Incorporated, alleging pat...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
